HOME >> BIOLOGY >> NEWS
EMBO to coordinate EU funded project to support science teachers

The European Molecular Biology Organization (EMBO) announces the signing of a contract for EURO 710.000 with the European Commission to coordinate a project under the title "Continuing Education for European Biology Teachers". EMBO, the EMBL (European Molecular Biology Laboratory) and the EFB (European Federation of Biotechnology) join forces in 2003 and 2004 to deliver a series of eight national and one international teachers workshops, to create a practical training programme for teachers and scientists, and to develop, archive and distribute the best teaching resources.

EMBO is organizing the workshops in conjunction with first-class European scientific institutes as local partners, ensuring that participants will gain insights into state-of-the-art methods and knowledge on hot scientific topics. The workshops will be held in Hamburg, Copenhagen, Madrid, Prague, Hinxton, Warsaw, Szeged and in Jerusalem in the native language of each country. The series will start with an international teachers workshop in English in Heidelberg (23-24 May 2003) aimed at widening the platform for international exchange.

"Improving the training opportunities for teachers is critical, and should occur increasingly at international level because of the vast benefits that can be gained by an exchange of experience and best practice between nations," says Andrew Moore, EMBO Science and Society Programme Manager. "As Europe becomes increasingly integrated at a scientific and economic level, it also has to become more integrated at the educational level, given the importance of professional mobility in the European work force today."

A second goal of the collaboration is to create a training programme that will bring teachers into the lab for hands-on activities, train scientists to work with them, and develop new assets for biology teaching. A facility will be established at the EMBL in Heidelberg putting in place staff that will perform practical activities with
'"/>

Contact: Ellen Peerenboom
ellen.peerenboom@embo.org
49-622-188-91108
European Molecular Biology Laboratory
7-Feb-2003


Page: 1 2

Related biology news :

1. AIBS tapped to coordinate design of ecological observatories
2. UCSD study of uncoordinated fruit flies provides molecular clues to hearing problems in humans
3. Should publicly funded research be free and available to the public?
4. RSRF-funded study leads to breakthrough for Rett Syndrome research
5. NIEHS-funded researchers find low-level ozone increases respiratory risk of asthmatic children
6. Interdisciplinary coral bleaching research funded
7. NSF-funded researchers track Alaska seal migration for the first time
8. Research funded to develop plant-based diabetes treatment
9. Research funded to test new breast cancer medicine
10. NICHD funded researchers first to genetically modify non human primate
11. NSF-funded scientists to examine environment at the molecular level

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EMBO coordinate funded project support science teachers

(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a leading ... that its DigitalPersona ® Pro Enterprise software ... been deployed throughout First Bank branch locations in ... South Carolina and Virginia. First Bank, a ... Southern Pines, North Carolina , selected the ...
(Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
(Date:12/15/2014)... & PETACH TIKVAH, Israel ... (NASDAQ: BCLI ), a leading developer of ... that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. was awarded ... Israel,s Office of the Chief Scientist (OCS).  ... in receipt of grant support from the Office of ...
(Date:12/15/2014)... NEW YORK , Dec. 15, 2014  GlassesOff ... Yuval Bar-Gil as an independent director of ... was founder of AeroScout and served as its CEO ... Decker in 2012, a $240 million transaction. Recognized as ... under Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID ...
(Date:12/15/2014)... 15, 2014  Ascendis Pharma A/S, a biotechnology ... address significant unmet medical needs, today announced positive ... pediatric study to evaluate once-weekly TransCon Growth Hormone ... This interim analysis consists of 25 patients, representing ... the study, completing all six months of treatment. ...
(Date:12/13/2014)... - MaRS and Virgin Unite Canada, the non-profit foundation of ... to support Canadian entrepreneurs tackling social and environmental challenges. Today, ... the MaRS Centre to announce the new partnership, which includes ... fund has $1 million in seed capital provided by Virgin ... Social Innovation Foundation, founded by Alison Lawton . ...
Breaking Biology Technology:BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
Cached News: